Publisher
Springer International Publishing
Reference52 articles.
1. Arshad N, Cresswell P (2018) Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I. J Biol Chem 293(25):9555–9569
2. Bilich T (2022) Characterization of T-cell epitopes for antigen-specific immunotherapy concepts targeting myeloproliferative neoplasms and multiple myeloma. Universität Tübingen
3. Braun LM, Zeiser R (2020) Immunotherapy in myeloproliferative diseases. Cells 9(6):1559
4. Cardoso EM, Esgalhado AJ, Patrão L, Santos M, Neves VP, Martinez J et al (2018) Distinctive CD8+ T cell and MHC class I signatures in polycythemia vera patients. Ann Hematol 97:1563–1575
5. Chowell D, Krishna C, Pierini F, Makarov V, Rizvi NA, Kuo F et al (2019) Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy. Nat Med 25(11):1715–1720. https://doi.org/10.1038/s41591-019-0639-4